Novartis AG CEO Vas Narasimhan said the company saw a very good performance across both established medicines and recent drug launches in the first quarter. He speaks with Bloomberg's Guy Johnson, Kriti Gupta, and Anna Edwards
Bloomberg Talks
2,470 clip(s)
Amazon Robotics Chief Technologist Tye Brady Talks Physical AI
US Trade Representative Jamieson Greer Talks Trade, TikTok & Nvidia
Chief Economist at Wolfe Research Stephanie Roth Talks November US CPI Report